137 related articles for article (PubMed ID: 12801313)
1. Effects of mediator antagonism on mannitol and adenosine monophosphate challenges.
Currie GP; Haggart K; Lee DK; Fowler SJ; Wilson AM; Brannan JD; Anderson SD; Lipworth BJ
Clin Exp Allergy; 2003 Jun; 33(6):783-8. PubMed ID: 12801313
[TBL] [Abstract][Full Text] [Related]
2. Fexofenadine decreases sensitivity to and montelukast improves recovery from inhaled mannitol.
Brannan JD; Anderson SD; Gomes K; King GG; Chan HK; Seale JP
Am J Respir Crit Care Med; 2001 May; 163(6):1420-5. PubMed ID: 11371412
[TBL] [Abstract][Full Text] [Related]
3. Single-dose desloratadine and montelukast and allergen-induced late airway responses.
Davis BE; Illamperuma C; Gauvreau GM; Watson RM; O'Byrne PM; Deschesnes F; Boulet LP; Cockcroft DW
Eur Respir J; 2009 Jun; 33(6):1302-8. PubMed ID: 19164343
[TBL] [Abstract][Full Text] [Related]
4. Role of cysteinyl leukotrienes in adenosine 5'-monophosphate induced bronchoconstriction in asthma.
Rorke S; Jennison S; Jeffs JA; Sampson AP; Arshad H; Holgate ST
Thorax; 2002 Apr; 57(4):323-7. PubMed ID: 11923550
[TBL] [Abstract][Full Text] [Related]
5. The effects of histamine and leukotriene receptor antagonism on nasal mannitol challenge in allergic rhinitis.
Lee DK; Haggart K; Currie GP; Anderson SD; Lipworth BJ
Br J Clin Pharmacol; 2003 Jun; 55(6):639-42. PubMed ID: 12814463
[TBL] [Abstract][Full Text] [Related]
6. Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen.
Davis BE; Todd DC; Cockcroft DW
J Allergy Clin Immunol; 2005 Oct; 116(4):768-72. PubMed ID: 16210049
[TBL] [Abstract][Full Text] [Related]
7. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
[TBL] [Abstract][Full Text] [Related]
8. Relationship between airway hyperresponsiveness to mannitol and adenosine monophosphate.
Currie GP; Haggart K; Brannan JD; Lee DK; Anderson SD; Lipworth BJ
Allergy; 2003 Aug; 58(8):762-6. PubMed ID: 12859555
[TBL] [Abstract][Full Text] [Related]
9. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Soccio AL; Ferrannini A; Vacca A
Br J Dermatol; 2006 Dec; 155(6):1279-82. PubMed ID: 17107402
[TBL] [Abstract][Full Text] [Related]
10. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study.
Nettis E; Colanardi MC; Paradiso MT; Ferrannini A
Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373
[TBL] [Abstract][Full Text] [Related]
11. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine.
Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P
J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097
[TBL] [Abstract][Full Text] [Related]
12. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
[TBL] [Abstract][Full Text] [Related]
13. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria.
Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB
J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A1 receptor antagonist versus montelukast on airway reactivity and inflammation.
Nadeem A; Obiefuna PC; Wilson CN; Mustafa SJ
Eur J Pharmacol; 2006 Dec; 551(1-3):116-24. PubMed ID: 17027749
[TBL] [Abstract][Full Text] [Related]
15. Montelukast, a leukotriene receptor antagonist, in combination with loratadine, a histamine receptor antagonist, in the treatment of chronic asthma.
Reicin A; White R; Weinstein SF; Finn AF; Nguyen H; Peszek I; Geissler L; Seidenberg BC
Arch Intern Med; 2000 Sep; 160(16):2481-8. PubMed ID: 10979060
[TBL] [Abstract][Full Text] [Related]
16. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group.
Altman LC; Munk Z; Seltzer J; Noonan N; Shingo S; Zhang J; Reiss TF
J Allergy Clin Immunol; 1998 Jul; 102(1):50-6. PubMed ID: 9679847
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
